Press releases

Top Score on Disability Equality Index Demonstrates Ongoing Progress in Creating Employment Opportunities for People with Disabilities FRANKLIN LAKES, N.J., July 11, 2023 /PRNewswire/ -- BD...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its third quarter of fiscal year 2023 on...

FRANKLIN LAKES, N.J. (June 22, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Brooke Story has been named president of...

Divestiture Advances BD2025 Strategy to Simplify Portfolio and Focus on Higher-Growth Markets FRANKLIN LAKES, N.J., June 20, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a...

BD FACSDuet™ Premium System Leverages Robotics to Automate Sample Preparation for Greater Standardization in Clinical Flow Cytometry Diagnostics FRANKLIN LAKES, N.J., June 12, 2023 /PRNewswire/...

Awards and new survey findings represent important milestones on non-profit healthcare consortium’s path to changing expectations around resiliency The following press release was issued by the...

DUBLIN (2 June 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today held a grand opening ceremony for a new €4 million research and...

FRANKLIN LAKES, N.J. (June 1, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that Laura Boros has been named president of...

BD PosiFlush™ SafeScrub Streamlines Clinical Workflow for Disinfecting and Flushing IV Catheters to Help Improve Patient Care FRANKLIN LAKES, N.J., May 23, 2023 /PRNewswire/ -- BD (Becton,...

BD FACSDiscover™ S8 Cell Sorter First to Combine Spectral Flow Cytometry with Real-Time Imaging Technology FRANKLIN LAKES, N.J., May 18, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company)...

BD Kiestra™ MRSA Imaging Application Helps Enhance Microbiology Laboratory Efficiency and Workflow FRANKLIN LAKES, N.J., May 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:...

Five organizations are collaborating to evaluate recycling program for blood collection tubes at Odense University Hospital COPENHAGEN, Denmark, May 8, 2023 /PRNewswire/ -- A new health care...

BD 2025 Strategic Investments Driving Growth and Advancing Innovation; Company Raises Mid-point of Revenue and Adjusted EPS Guidance Ranges Revenue of $4.8 billion increased 1.5% as reported and...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named a "Noteworthy Company" in DiversityInc's annual ranking of the...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities 2023 Health Care Conference on...

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable on June 30, 2023 to holders of record on June 9, 2023....

Accolade Represents Positive Perceptions from Employees and Progress in Advancing ESG Strategy FRANKLIN LAKES, N.J., April 25, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX),...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released findings from a survey conducted online by The Harris Poll, reporting that women feel...

BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J., April 11, 2023 /PRNewswire/ -- BD (Becton,...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its second quarter of fiscal year 2023 on...

FRANKLIN LAKES, N.J., April 3, 2023 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Michelle Quinn has been named executive vice...

BD Vaginal Panel on BD COR™ System Tests for Multiple Common Types of Vaginitis Using Only One Swab, One Test FRANKLIN LAKES, N.J., March 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays Global Healthcare Conference on Wednesday, March...

FRANKLIN LAKES, N.J. (Feb. 23, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the outcomes of a peer-reviewed study that...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Cowen 43rd Annual Healthcare Conference on Monday, March 6,...

Expands Access to BD HPV Test that More Precisely Identifies Patients' Risk for Cervical Cancer FRANKLIN LAKES, N.J., Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX),...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that the company has been named to America's Best Large Employers List 2023 by Forbes,...

Single Test on BD MAX™ Molecular Diagnostic System Identifies and Differentiates Multiple Respiratory Infectious Diseases FRANKLIN LAKES, N.J., Feb. 8, 2023 /PRNewswire/ -- BD (Becton, Dickinson...

New BD Rhapsody™ HT Xpress System and Other Innovations to be Unveiled at AGBT, Enhancing an End-To-End Single-Cell Multiomics Offering FRANKLIN LAKES, N.J., Feb. 3, 2023 /PRNewswire/ -- BD...

Execution of BD 2025 Strategy Delivering Consistent and Durable Performance Revenue of $4.6 billion decreased 2.8% as reported and increased 1.7% on a currency-neutral basis Revenue from base...

Company's Ongoing Commitment to Advance Workplace Equality Shows Progress in Female Leadership and Talent Pipeline FRANKLIN LAKES, N.J., Jan. 31, 2023 /PRNewswire/ -- BD (Becton, Dickinson and...

Highlights Critical Importance of Transparency and Collaboration FRANKLIN LAKES, N.J., Jan. 25, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable on March 31, 2023 to holders of record on March 10,...

The 3rd Generation BD Kiestra™ Total Lab Automation System Offers Flexible Instrument to Optimize Lab Space and Streamline Workflow FRANKLIN LAKES, N.J., Jan. 11, 2023 /PRNewswire/ -- BD...

Assay for Research and Clinical Use Now Globally Available for the BD MAX™ System FRANKLIN LAKES, N.J., Jan. 9, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday,...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michelle Quinn has been named acting general counsel of BD, succeeding Samrat...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its first quarter of fiscal year 2023 on...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released findings from a survey conducted by The Harris Poll, between Nov. 14-16, 2022, among 872...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday,...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the release of its second annual Global Inclusion, Diversity and Equity (ID&E) Report...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been named among the top 25% of Newsweek's list of America's Most Responsible...

TIJUANA, Baja California, Mexico (Nov. 30, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was joined by government officials from...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present virtually at the Evercore ISI 5th Annual HealthCONx Conference on...

Execution of BD 2025 Strategy Driving Consistent Durable Growth Q4 revenue from continuing operations of $4.8 billion decreased 1.8% as reported and increased 2.3% on a currency-neutral basis Q4...

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, an increase of 4.6% from the previous quarter. The dividend...

Ridgewood, NJ, November 2, 2022 – Valley-Mount Sinai Comprehensive Cancer Care is pleased to be the recipient of a $652,000 grant over three years from BD (Becton, Dickinson and Company), a...

FRANKLIN LAKES, N.J. (Oct. 26, 2022) – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced its enterprise-level Information Security Management...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Magnolia Medical Technologies, Inc., today announced a co-exclusive commercial agreement aimed at...

FRANKLIN LAKES, N.J. (October 17, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biocorp, a medical device and delivery systems...